Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study

  • Mazen G. Jabre, Parkinson, Memory & Movement Disorders Center, Notre Dame des Secours Hospital, Byblos/Jbeil-Lebanon[email protected]
  • Boulos-Paul W Bejjani
Submitted June 27, 2005

VanItallie et al shed light on an underestimated therapeutic approach in the management of Parkinson disease (PD) based on diet modulation. [1] In their article, five patients at mild and advanced disease stages responded to a hyperketogenic diet (HKD) with a marked improvement of general motor disability. Authors were cautious, taking into consideration the small number of patients, the lack of a control group, as well as the possible placebo effect.

We agree with authors’ concerns but question the applicability of and compliance with such a complex diet in a naturalistic setting, even if there is firm evidence of HDK safety and efficacy in PD patients. Alternatively, the five reported PD patients were either overweight or obese had a body-mass index range of 28.4 to 35.9 kg/m². Losing body weight (mean, 6.1 kg; range 4.1-9.5 kg) was found to alter levodopa pharmacokinetics and led to an increase in levodopa cumulative dosage per kilogram of body weight. [2] Moreover, a greater levodopa bioavailability and brain level would be reached using a very low-protein diet. [3]

At a lower body weight and under tight protein restriction, the same oral levodopa dose that patients used to take when they were heavier or on regular diet, would lead to higher systemic levels. We therefore expect an ensuing heightened efficacy on parkinsonian symptoms and motor fluctuations and,at times, a putatively dyskinesogenic effect, as to require dosage reduction.

References

1.VanItallie TB, Nonas C, Di Rocco A, Boyar K, Hyams K, Heymsfield SB. Treatment of Parkinson’s disease with diet-induced hyperketonemia: A feasibility study. Neurology 2005; 64: 728-730.

2.Zappia M, Crescibene L, Arabia G, Nicoletti G, Bagala A, Bastone L, Caracciolo M, Bonavita S, Di Costanzo A, Scornaienchi M, Gambardella A, Quattrone A. Body weight influences pharmacokinetics of levodopa in Parkinson's disease. Clin Neuropharmacol 2002; 25: 79-82.

3.Pincus JH, Barry KM. Plasma levels of amino acids correlate with motor fluctuations in parkinsonism. Arch Neurol 1987; 44:1006-1009.

The authors report no conflicts of interest.

Navigate back to article

Neurology: 101 (22)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise